Literature DB >> 1680126

Criteria for selection of appropriate benzodiazepine hypnotic therapy.

J Mendels1.   

Abstract

The several benzodiazepine hypnotics currently marketed differ in onset and duration of action and in side effect profile. These differences are largely based on the varying pharmacodynamic properties of these agents. The selection of a drug for treating an individual patient should be based on consideration of these pharmacologic differences, as well as assessment of the sleep-wake disorder. The initial objective for the clinician who intends to manage a patient with insomnia is to determine which factors are contributing to the sleep disturbance and to decide on a treatment strategy. If medication is to be used, then the physician should select the most effective and safest hypnotic, prescribe it at the lowest effective dose and for the fewest number of nights. Individual patient response to the chosen medication should be monitored.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680126

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up.

Authors:  Rolf van Hulten; K Bart Teeuw; Albert Bakker; Hubert G Leufkens
Journal:  Eur J Clin Pharmacol       Date:  2003-02-07       Impact factor: 2.953

Review 2.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

3.  Evaluation of effectiveness and safety of a herbal compound in primary insomnia symptoms and sleep disturbances not related to medical or psychiatric causes.

Authors:  Giancarlo Palmieri; Paola Contaldi; Giuseppe Fogliame
Journal:  Nat Sci Sleep       Date:  2017-05-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.